Form4.ai tracks every SEC insider trade in real time. See every MGX insider filing with a free account — no card.
See every MGX insider filing — free account, no card.
Free accountMetagenomi Therapeutics, Inc. (MGX) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $23K, and 3 sales totalling $5K. Most recent filing: Sept. 11, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 11, 2026 SEC filing | Reid Laurence Director | Bought | $23,401 | -15.1% 30D |
| Sep 10, 2026 SEC filing | Wein Matthew See Remarks | Sold | $415 | — |
| Sep 10, 2026 SEC filing | Irish Jian See Remarks | Sold | $2,479 | — |
Create a free account to see all 4 MGX filings from the last 90 days. No card needed.
Create free accountWant MGX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.